SCHEMBL5717506

SCHEMBL5717506

O=C(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ P2RY6 Q15077 2/20 0.48
▸ P2RY14 Q15391 2/20 0.48
▸ NT5E P21589 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ LMNA P02545 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ HBB P68871 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ HTT P42858 1/20 0.46
▸ GAPDH P04406 2/20 0.44
▸ P2RY2 P41231 2/20 0.43
▸ P2RY12 Q9H244 1/20 0.43
▸ RNASE1 P07998 1/20 0.42
▸ CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717501 1.00 MEN1 (0.55) MEN1USP2POLBKMT2AP2RY6
SCHEMBL5080725 0.92 MEN1 (0.61) MEN1USP2POLBKMT2AP2RY6
SCHEMBL20983914 0.92 MEN1 (0.61) MEN1USP2POLBKMT2AP2RY6
SCHEMBL9002102 0.92 MEN1 (0.61) MEN1USP2POLBKMT2AP2RY6
SCHEMBL7942376 0.92 MEN1 (0.61) MEN1USP2POLBKMT2AP2RY6
SCHEMBL9002093 0.92 MEN1 (0.61) MEN1USP2POLBKMT2AP2RY6
SCHEMBL25399138 0.91 MEN1 (0.55) MEN1USP2POLBKMT2AP2RY6
SCHEMBL11872402 0.90 RNASE1 (0.50) P2RY6P2RY14NT5ELMNATSHR
SCHEMBL25398726 0.90 MEN1 (0.54) MEN1USP2POLBKMT2AP2RY6
SCHEMBL9137347 0.89 MEN1 (0.55) MEN1USP2POLBKMT2AP2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124565-B1 AZIDO DERIVATIVES OF BETA-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION CENTRE NAT RECH SCIENT (FR) 2006-03-29 — — EP disclosed
EP-1124839-B1 NUCLEOSIDES WITH ANTI-HEPATITIS B VIRUS ACTIVITY CENTRE NAT RECH SCIENT (FR) 2006-01-11 — — EP disclosed
US-6896900-B2 β-L-2'-deoxy-nucleosides for the treatment of HIV infection EMORY UNIVERSITY (US) 2005-05-24 — — US disclosed
US-6458773-B1 ADMINISTERING AN EFFECTIVE AMOUNT OF A .BETA.-L-(2'OR 3'-AZIDO)2',3'-DIDEOXY-5-FLUOROCYTOSINE WHEREIN R IS H, ACYL, MONOPHOSPHATE, DIPHOSPHATE, OR TRIPHOSPHATE, OR A STABILIZED PHOSPHATE DERIVATIVE (TO FORM A STABILIZED NUCLEOTIDE EMORY UNIVERSITY 2002-10-01 — — US disclosed
US-6407077-B1 ADMINISTERING B-L-(-2*-AZIDO)-2*,3*-DIDEOXY-5-FLUOROCYTIDINE DERIVATIVE; ACQUIRED IMMUNE DEFICIENCY SYNDROMOE (AIDS) TREATMENT EMORY UNIVERSITY 2002-06-18 — — US disclosed
EP-1124565-A1 AZIDO DERIVATIVES OF BETA-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-08-22 — — EP disclosed
WO-2000025799-A1 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2000-05-11 — — WO disclosed
Send feedback